These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patients. Billard C, Ferbus D, Diez RA, Kolb JP, Mathiot C, Belanger C, Auzanneau G, Varet B, Falcoff E, Dumont J. Leuk Res; 1991; 15(2-3):121-8. PubMed ID: 1826751 [Abstract] [Full Text] [Related]
26. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro. Ruzicka FJ, Schmid SM, Groveman DS, Cummings KB, Borden EC. Cancer Res; 1987 Sep 01; 47(17):4582-9. PubMed ID: 2957045 [Abstract] [Full Text] [Related]
34. Kinetic evidence for an activation step following binding of human interferon alpha 2 to the membrane receptors of Daudi cells. Mogensen KE, Bandu MT. Eur J Biochem; 1983 Aug 01; 134(2):355-64. PubMed ID: 6307693 [Abstract] [Full Text] [Related]
35. [Receptor system of interferons]. Yonehara S. Gan To Kagaku Ryoho; 1984 Jan 01; 11(1):44-52. PubMed ID: 6320747 [Abstract] [Full Text] [Related]
37. The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon. Pfeffer LM, Donner DB. Cancer Res; 1990 May 01; 50(9):2654-7. PubMed ID: 2139358 [Abstract] [Full Text] [Related]